BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29453521)

  • 21. Radioguided occult lesion localisation using iodine-125 seeds ('ROLLIS') for removal of impalpable breast lesions: First Australian experience.
    Taylor DB; Bourke AG; Westcott E; Burrage J; Latham B; Riley P; Ballal H; Kamyab R; Frost F; Dissanayake D; Landman J; Phillips M; Saunders C
    J Med Imaging Radiat Oncol; 2015 Aug; 59(4):411-420. PubMed ID: 25871837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iodine-125 seeds to guide removal of impalpable breast lesions: radio-guided occult lesion localization - a pilot study.
    Bourke AG; Taylor DB; Westcott E; Hobbs M; Saunders C
    ANZ J Surg; 2017 Nov; 87(11):E178-E182. PubMed ID: 26990046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective Review of Preoperative Radiofrequency Tag Localization of Breast Lesions in 848 Patients.
    Lamb LR; Gilman L; Specht M; D'Alessandro HA; Miles RC; Lehman CD
    AJR Am J Roentgenol; 2021 Sep; 217(3):605-612. PubMed ID: 33084384
    [No Abstract]   [Full Text] [Related]  

  • 24. Radioactive and non-radioactive seeds as surgical localization method of non-palpable breast lesions.
    Cebrecos I; Sánchez-Izquierdo N; Ganau S; Mensión E; Perissinotti A; Úbeda B; Bargalló X; Alonso I; Vidal-Sicartb S
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(2):100-107. PubMed ID: 35193816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magseed placement before neoadjuvant chemotherapy to facilitate subsequent breastconserving surgery - a single-centre audit.
    Malherbe F; Roodt L; Noor F; Gamieldien R; Chetty D; Anderson D; Thebe T; Cairncross L
    S Afr J Surg; 2022 Jun; 60(2):109-114. PubMed ID: 35851364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioactive seed localization with 125I for nonpalpable lesions prior to breast lumpectomy and/or excisional biopsy: methodology, safety, and experience of initial year.
    Dauer LT; Thornton C; Miodownik D; Boylan D; Holahan B; King V; Brogi E; Morrow M; Morris EA; St Germain J
    Health Phys; 2013 Oct; 105(4):356-65. PubMed ID: 23982612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of shared learning of a new magnetic seed localisation device - A UK iBRA-NET breast cancer localisation study.
    Morgan JL; Bromley HL; Dave RV; Masannat Y; Masudi T; Mylvaganam S; Elgammal S; Barnes N; Down S; Holcombe C; Potter S; Gardiner MD; Maxwell AJ; Somasundaram SK; Sami A; Kirwan C; Harvey J;
    Eur J Surg Oncol; 2022 Dec; 48(12):2408-2413. PubMed ID: 36068125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wire- and magnetic-seed-guided localization of impalpable breast lesions: iBRA-NET localisation study.
    Dave RV; Barrett E; Morgan J; Chandarana M; Elgammal S; Barnes N; Sami A; Masudi T; Down S; Holcombe C; Potter S; Somasundaram SK; Gardiner M; Mylvaganam S; Maxwell A; Harvey J;
    Br J Surg; 2022 Feb; 109(3):274-282. PubMed ID: 35089321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioactive seed localization for nonpalpable breast lesions: review of 1,000 consecutive procedures at a single institution.
    McGhan LJ; McKeever SC; Pockaj BA; Wasif N; Giurescu ME; Walton HA; Gray RJ
    Ann Surg Oncol; 2011 Oct; 18(11):3096-101. PubMed ID: 21947587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A German Study Comparing Standard Wire Localization With Magnetic Seed Localization of Non-palpable Breast Lesions.
    Kühn F; Simon CEE; Aliyeva I; KUßMAUL J; GROß J; Schweizerhof O; Blohmer JU; Karsten MM
    In Vivo; 2020; 34(3):1159-1164. PubMed ID: 32354905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient and clinician satisfaction and clinical outcomes of Magseed compared with wire-guided localisation for impalpable breast lesions.
    Micha AE; Sinnett V; Downey K; Allen S; Bishop B; Hector LR; Patrick EP; Edmonds R; Barry PA; Krupa KDC; Rusby JE
    Breast Cancer; 2021 Jan; 28(1):196-205. PubMed ID: 32974810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation safety with use of I-125 seeds for localization of nonpalpable breast lesions.
    Pavlicek W; Walton HA; Karstaedt PJ; Gray RJ
    Acad Radiol; 2006 Jul; 13(7):909-15. PubMed ID: 16777565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization.
    Gray RJ; Salud C; Nguyen K; Dauway E; Friedland J; Berman C; Peltz E; Whitehead G; Cox CE
    Ann Surg Oncol; 2001 Oct; 8(9):711-5. PubMed ID: 11597011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolving Role of Magseed in Wireless Localization of Breast Lesions: Systematic Review and Pooled Analysis of 1,559 Procedures.
    Gera R; Tayeh S; Al-Reefy S; Mokbel K
    Anticancer Res; 2020 Apr; 40(4):1809-1815. PubMed ID: 32234869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Handling of radioactive seed localization breast specimens in the pathology laboratory.
    Graham RP; Jakub JW; Brunette JJ; Reynolds C
    Am J Surg Pathol; 2012 Nov; 36(11):1718-23. PubMed ID: 23060351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pilot Study of a New Nonradioactive Surgical Guidance Technology for Locating Nonpalpable Breast Lesions.
    Cox CE; Garcia-Henriquez N; Glancy MJ; Whitworth P; Cox JM; Themar-Geck M; Prati R; Jung M; Russell S; Appleton K; King J; Shivers SC
    Ann Surg Oncol; 2016 Jun; 23(6):1824-30. PubMed ID: 26847680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a Nonradioactive Magnetic Marker Wireless Localization Program.
    Lamb LR; Bahl M; Specht MC; D'Alessandro HA; Lehman CD
    AJR Am J Roentgenol; 2018 Oct; 211(4):940-945. PubMed ID: 30085842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Starting a Radioactive Seed Localization Program.
    Jakub J; Gray R
    Ann Surg Oncol; 2015 Oct; 22(10):3197-202. PubMed ID: 26254168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiofrequency localization of nonpalpable breast cancer in a multicentre prospective cohort study: feasibility, clinical acceptability, and safety.
    Christenhusz A; den Dekker BM; van Dalen T; Jongen L; van der Schaaf MC; Alic L; Ten Haken B; Pijnappel RM; Dassen AE
    Breast Cancer Res Treat; 2023 Aug; 201(1):67-75. PubMed ID: 37322358
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.